| SOURCE |
LINK |
ARTICLE |
DATE |
| Business Wire |
|
Oncolin Therapeutics Announces Appointment of Chair of Scientific Advisory Committee |
2008-07-16 |
| Business Wire |
|
Oncolin Therapeutics Announces the Discovery of a New More Effective Anti-Cancer Treatment in Experimental Brain Tumor Models |
2008-06-30 |
| Business Wire |
|
Oncolin Appoints Member of National Cancer Institute Advisory Board to Its Scientific Advisory Board |
2008-06-23 |
| Business Wire |
|
Oncolin Therapeutics Announces Its Cancer Technology Will Be Presented at the 20th EORTC-NCI-AACR Symposium |
2008-06-19 |
| Business Wire |
|
Oncolin Therapeutics Signs Agreement with Leading Cancer Center |
2008-06-10 |
| Business Wire |
|
Oncolin Therapeutics Announces Its New 'Super Cell Blocker', ONC-127, Has Shown Effectiveness in Treating Cancer |
2008-05-13 |
| Business Wire |
|
Oncolin Therapeutics Announces That Dr. Randall K. Johnson Has Agreed to Join Its Scientific Advisory Board |
2008-05-05 |
| Business Wire |
|
Oncolin Therapeutics Announces the Addition of Dr. Sandra Silberman to Its Scientific Advisory Board |
2008-04-16 |
| Business Wire |
|
Oncolin Therapeutics Lead Cancer Technology is Being Presented Today at the Annual Meeting of The American Association for Cancer Research |
2008-04-15 |
| Business Wire |
|
Oncolin Therapeutics Announces Its Lead Technology Has Shown to Be Effective in Treating Cancer in Animal Models |
2008-04-14 |
| Business Wire |
|
Oncolin Therapeutics Announces It Has Entered into Negotiations with a Leading Institution to Commercially Develop a Cancer Technology |
2008-04-08 |
| Business Wire |
|
Oncolin Therapeutics Obtains an Exclusive Worldwide Right to Option Patents Covering the Composition and Use of Genistein Analogs for Cancer Treatment |
2008-04-01 |
| Business Wire |
|
Market Advisors, Inc. Initiates Coverage on Oncolin Therapeutics, Inc. |
2008-03-31 |
| Business Wire |
|
Oncolin Therapeutics Provides a Company Overview |
2008-03-25 |
| Business Wire |
|
Edgeline Holdings to Add Industry Veteran to Its Scientific Advisory Board |
2008-03-06 |
| Business Wire |
|
Edgeline Holdings Agrees to Terms for an Exclusive Worldwide Right to Option Patents Covering the Composition and Use of Genistein Analogs for Cancer Treatment |
2008-02-26 |
| Business Wire |
|
Edgeline Holdings Announces an Agreement that Provides Enabling Technology for Its Lead Clinical Program |
2008-02-19 |
| Business Wire |
|
Edgeline Holdings Announces Its Research Program Receives Peer Reviewed National Institute of Health Grant of $179,000 |
2008-02-13 |
| Business Wire |
|
Edgeline Holdings Announces a Strategic Business Change to Focus Exclusively on Biotechnology and is Changing Its Name to Oncolin Therapeutics, Inc. |
2008-02-11 |
| Business Wire |
|
Edgeline Holdings Announces Donald Picker Has Joined the Company as Its Acting Chief Operating Officer |
2008-01-08 |
| Business Wire |
|
Edgeline Holdings Expects to Close on Its $10 Million Funding Agreement by Next Week and Provides Update |
2007-12-13 |
| Business Wire |
|
Edgeline Holdings Signs Joint Development Agreement with Houston Pharmaceuticals |
2007-12-11 |
| Business Wire |
|
Edgeline Holdings Signs Exclusive Option Agreement with The University of Texas M. D. Anderson Cancer Center |
2007-12-05 |
| Business Wire |
|
Edgeline Holdings Announces the Acquisition of Intertech Bio Has Been Completed |
2007-12-04 |
| Business Wire |
|
Edgeline Holdings Completes the Field Testing of Its Potential Technology Acquisition |
2007-11-01 |
| Business Wire |
|
Edgeline Holdings Announces It Has Executed a $10,000,000 Funding Term Sheet |
2007-10-30 |
| Business Wire |
|
Edgeline Holdings Announces Receipt of $7,500,000 Funding Proposal |
2007-10-17 |
| Business Wire |
|
Edgeline Holdings to Close on Its Acquisition of Intertech Bio |
2007-10-15 |
| Business Wire |
|
Edgeline Holdings Schedules Field Testing of Its Potential Acquisition Which Addresses the Multi-Billion-Dollar Enhanced Oil Recovery Industry |
2007-10-11 |
| Business Wire |
|
Edgeline Holdings' Subsidiary, New EnerSource, Enters Due Diligence Phase on Its Potential Acquisition of an Enhanced Oil Recovery Technology |
2007-09-18 |
| Business Wire |
|
Equity Stock Analysis Announces Research Coverage of Edgeline Holdings with a Rating of ''Attractive'' and a Price Target of $1.50 |
2007-09-12 |
| Business Wire |
|
Edgeline Holdings Subsidiary, New EnerSource, Enters Negotiations to Acquire an Enhanced Oil Recovery Technology |
2007-09-05 |
| Business Wire |
|
Edgeline Holdings Forms New Subsidiary, New EnerSource, to Develop Enhanced Oil Recovery Technologies |
2007-08-28 |
| Business Wire |
|
Edgeline Holdings Reaches Agreement to Acquire Intertech Bio |
2007-08-10 |
| Business Wire |
|
Edgeline Announces Formation of Strategic Technology Advisory Board |
2007-08-02 |
| Business Wire |
|
Edgeline Announces Its New 'ALAS' Application Which Addresses the Multibillion-Dollar VoIP Market Will Be Ready for Beta within 60 Days |
2007-07-31 |
| Business Wire |
|
Edgeline Holdings Completes the Acquisiton of Secure Voice Communications, a VoIP Security Company |
2007-07-25 |